Cargando…
RASSF10 suppresses colorectal cancer growth by activating P53 signaling and sensitizes colorectal cancer cell to docetaxel
RASSF10 has previously been reported to be frequently methylated in a number of malignancies. To understand the importance of RASSF10 inactivation in colorectal carcinogenesis, eight colorectal cancer cell lines, 89 cases of primary colorectal cancer and 5 cases of normal colorectal mucosa were exam...
Autores principales: | Guo, Jing, Yang, Yage, Yang, Yunsheng, Linghu, Enqiang, Zhan, Qimin, Brock, Malcolm V., Herman, James G., Zhang, Bingyong, Guo, Mingzhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414183/ https://www.ncbi.nlm.nih.gov/pubmed/25638156 |
Ejemplares similares
-
RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant marker
por: Jin, Yongshuai, et al.
Publicado: (2015) -
Methylation of CHFR sensitizes esophageal squamous cell cancer to docetaxel and paclitaxel
por: Yun, Tianyang, et al.
Publicado: (2015) -
Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth
por: Wang, Yuzhu, et al.
Publicado: (2017) -
Correction to: Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth
por: Wang, Yuzhu, et al.
Publicado: (2018) -
Silencing NKD2 by promoter region hypermethylation promotes gastric cancer invasion and metastasis by up-regulating SOX18 in human gastric cancer
por: Jia, Yan, et al.
Publicado: (2015)